共 25 条
[2]
Impact of parietal cell autoantibodies and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis C virus infection: A pilot study[J]. Nikolaos K.Gatselis,Sarah P.Georgiadou,Nikolaos Tassopoulos,Kalliopi Zachou,Christos Liaskos,Angelos Hatzakis,Georgios N.Dalekos.World Journal of Gastroenterology. 2005(04)
[3]
Review article: autoimmune hepatitis – current management and challenges[J] . K. Zachou,P. Muratori,G. K. Koukoulis,A. Granito,N. Gatselis,A. Fabbri,G. N. Dalekos,L. Muratori.Aliment Pharmacol Ther . 2013 (8)
[4]
Clinical significance of the fluctuation of primary biliary cirrhosis-related autoantibodies during the course of the disease*[J] . Nikolaos K. Gatselis,Kalliopi Zachou,Gary L. Norman,Stella Gabeta,Panagiotis Papamichalis,George K. Koukoulis,George N. Dalekos.Autoimmunity . 2013 (7)
[5]
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection[J] . European Association for the Study of the Liver.Journal of Hepatology . 2012 (1)
[8]
HBV and HCV chronic infection: Autoimmune manifestations and lymphoproliferation[J] . Anna Linda Zignego,Alessia Piluso,Carlo Giannini.Autoimmunity Reviews . 2008 (2)
[10]
Descriptive epidemiology of chronic hepatitis B by using data from a hepatitis registry in Central Greece[J] . Aggelos Stefos,Nikolaos Gatselis,Kalliopi Zachou,Eirini Rigopoulou,Christos Hadjichristodoulou,George N. Dalekos.European Journal of Internal Medicine . 2008 (1)